They are not intended for human use and have not been evaluated by the FDA for diagnosing, treating, curing, or preventing any disease
Not every long COVID patient is an appropriate candidate for peptide therapy and that's okay
Reduces cell damage in alcoholic and nonalcoholic fatty liver disease Cell death in the liver may be exacerbated by a deficiency in antioxidants, including glutathione
In adipose tissue, inhibition of NNMT suppresses de novo lipogenesis, normalizes fat content, and improves insulin sensitivity 2-3
Despite their diverse pharmacological properties, these substances converge on shared mechanisms of neurotoxicity, including oxidative stress, mitochondrial dysfunction, excitotoxicity, and neuroinflammation
otros no encuentran efecto